These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 227532)

  • 1. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H] Quinuclidinyl benzylate and [3H] GABA receptor binding in rat substantia nigra after 6-hydroxy-dopamine lesions.
    Cross AJ; Waddington JL
    Neurosci Lett; 1980 May; 17(3):271-5. PubMed ID: 6302586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
    Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
    J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotransmitter receptor localizations: brain lesion induced alterations in benzodiazepine, GABA, beta-adrenergic and histamine H1-receptor binding.
    Chang RS; Tran VT; Snyder SH
    Brain Res; 1980 May; 190(1):95-110. PubMed ID: 6103733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding experiments of muscarinic acetylcholine and dopamine receptors in human brains with emphasis on a case of striatonigral degeneration.
    Shimoyama M; Kito S; Itoga E; Kishida T; Nanba K
    Jpn J Pharmacol; 1982 Dec; 32(6):1157-66. PubMed ID: 6819376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in [3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography.
    Pan HS; Frey KA; Young AB; Penney JB
    J Neurosci; 1983 Jun; 3(6):1189-98. PubMed ID: 6304260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of brain lesions on [3H]ohmefentanyl binding site densities in the rat striatum and substantia nigra.
    Masuo Y; Wang H; Pélaprat D; Chi ZQ; Rostène W
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2520-4. PubMed ID: 1332831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA receptor binding in rat striatum: localization and effects of denervation.
    Campochiaro P; Schwarcz R; Coyle JT
    Brain Res; 1977 Nov; 136(3):501-11. PubMed ID: 922498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in striatal [3H]muscimol binding following intrastriatal injection of kainic acid: a denervation supersensitivity phenomenon.
    Kuriyama K; Kurihara E; Ito Y; Yoneda Y
    J Neurochem; 1980 Aug; 35(2):343-8. PubMed ID: 6256483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the presynaptic localization of opiate binding sites on striatal efferent fibers.
    Abou-Khalil B; Young AB; Penney JB
    Brain Res; 1984 Dec; 323(1):21-9. PubMed ID: 6098334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
    Pan HS; Penney JB; Young AB
    J Neurochem; 1985 Nov; 45(5):1396-404. PubMed ID: 2995585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
    Araki T; Matsubara M; Fujihara K; Kato H; Imai Y; Itoyama Y
    Neurol Res; 2002 Jan; 24(1):107-12. PubMed ID: 11783749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of postsynaptic beta-adrenergic receptors and presynaptic muscarinic cholinergic receptors in the rat spleen.
    Yamada S; Yamamura HI; Roeske WR
    Life Sci; 1982 Sep; 31(11):1161-70. PubMed ID: 6292605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of striatal cholinergic receptors after lesioning of the substantia nigra.
    Sanvarinda Y; Phivthongngam L; Govitrapong P
    Neurochem Int; 1998 Aug; 33(2):187-93. PubMed ID: 9761463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine and opiate receptors: localization in the striatum and evidence for their axoplasmic transport in the nigrostriatal and striatonigral pathways.
    Van der Kooy D; Weinreich P; Nagy JI
    Neuroscience; 1986 Sep; 19(1):139-46. PubMed ID: 2431346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W
    Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.